Cerevance Media Center

Current News

April 13, 2023

Poster Presentation at the BNA International Festival of Neuroscience

Cerevance today announced a poster presentation at the British Neuroscience Association (BNA) 2023 International Festival of Neuroscience in Brighton, United Kingdom being held April 23-26, 2023

READ FULL

March 21, 2023

Cerevance to Present at Two Medicinal Chemistry Conferences

Cerevance to present at two upcoming medicinal chemistry conferences:

  • 7th RSC-BMCS / SCI Symposium on Ion Channels as Therapeutic Targets held March 27-28 in Cambridge, UK
  • Binding Kinetics and Mechanistic PK/PD Modeling in Early Drug Discovery Conference held March 27-28 in Cambridge, UK
READ FULL

March 20, 2023

Cerevance to Present at AD/PD™ 2023 International Conference

  • Positive CVN424 Phase 2 data for Parkinson’s disease to be presented
  • Presentation of NETSseq platform’s ability to reveal novel targets to inform CNS drug development
  • Novel target, CVN417, for the potential treatment of Parkinson’s disease to be disclosed
READ FULL

February 13, 2023

Cerevance Expands Series B Financing with Additional $51 Million

  • Proceeds will advance Cerevance’s potential first-in-class programs developed using proprietary NETSseq platform
  • CVN424 for Parkinson’s disease will advance to Phase 2 monotherapy study in Q2 2023
  • CVN766 for negative and cognitive symptoms of schizophrenia will advance to Phase 2 study in Q4 2023
  • CVN293 for Amyotrophic Lateral Sclerosis will advance to Phase 1 study in Q3 2023
READ FULL

News Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

February 22, 2024

Cerevance to Participate at the TD Cowen 44th Annual Health Care Conference

Date:
Monday, March 4, 2024
Time:
Scheduled Meetings
Location:
Boston, MA
Media:
Scheduled Meetings
Read full

December 5, 2023

Cerevance to Participate in Fireside Chat at the 2023 RBC Capital Markets Healthcare Private Company Virtual Conference

Date:
Thursday, December 14, 2023
Time:
1:10 – 1:40 pm ET
Location:
Virtual
Media:
Fireside Chat
Read full

November 28, 2023

Cerevance Announces Presentation at the 34th International Symposium on ALS/MND

Date:
Thursday, December 7, 2023
Time:
5:45 – 7:45pm CET
Location:
Basel, Switzerland
Media:
Poster
Read full

Events Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

August 14, 2023

A Covalent Binding Mode of a Pyrazole-Based CD38 Inhibitor

Doyle, K., Roberts, M., Harvey, J, Hewer, R., Zebisch, M., Rangel, V., Gu, M., Wu, Y., Yang, L., Carlton, M., Dawson, L. & Bürli, R.

Viewview

October 15, 2018

Species and Cell-Type Properties of Classically Defined Human and Rodent Neurons and Glia

Xu, X., Stoyanova, E.I., Lemiesz, A.E., Xing, J., Mash, D.C., Heintz, N.

Viewview